Concepedia
Statistics
Publications
59
Citations
2.5K
H-Index
32
Active since
1997
Affiliations
Novartis (United States)(Current)
Novartis (Switzerland)
Merck & Co., Inc., Rahway, NJ, USA (United States)
Janssen (Belgium)
Pfizer (United States)
Tycho Heimbach is an author at Novartis (United States) specializing in pharmacy, pharmacology, and pharmacokinetics.
Publications per year
1997–2025
Physiologically‐Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry Perspective
Tycho Heimbach, Yuan Chen, Jun Chen et al. · Clinical Pharmacology & Therapeutics · 2020 · 125 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +17
Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor
Young Shin Cho, Julian Levell, Gang Liu et al. · ACS Medicinal Chemistry Letters · 2017 · 118 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +7
Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link—a Workshop Summary Report
Tycho Heimbach, Sandra Suarez‐Sharp, Maziar Kakhi et al. · The AAPS Journal · 2019 · 104 citations
Pharmacy, Bioengineering, Bioavailability +9
Novel Orally Swallowable IntelliCap® Device to Quantify Regional Drug Absorption in Human GI Tract Using Diltiazem as Model Drug
D. E. Becker, Jin Zhang, Tycho Heimbach et al. · AAPS PharmSciTech · 2014 · 103 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +10
Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry Perspective
Arian Emami Riedmaier, Kevin DeMent, James E. Huckle et al. · The AAPS Journal · 2020 · 96 citations · Full text
1–5 of 59